A couple of days ago, the FDA approved Johnson & Johnson’s ketamine-like nasal spray for patients who suffer from “treatment-resistant” depression, which is apparently about 16 million American adults. The spray, called Spravato, which works by restoring brain cells, can be administered in a doctor’s office or clinic, or you can do it yourself – under supervision (and not at home). Spravato has all sorts of side effects — the most severe being out-of-body hallucinogenic sensations — so patients will be monitored for at least two hours after being given the drug. As for the cost, it’s up there. For the standard regimen, you’re looking at $5000-$7000 for the first month; $2500-$3,500 a month thereafter. Johnson & Johnson says it expects most insurance plans to pay for the drug, but we all know how that goes….

 Get NoPo Delivered Daily

We hate SPAM as much as you do! Rest assured, your information stays private as per our privacy policy.

Connect With Us